High-mobility group box-1 protein, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in children with community acquired infections and bacteraemia: A prospective study

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Pavare, Jana ^a   Grope, Ilze ^a   Kalnins, Imants ^a   Gardovska, Dace ^a  

^a RIGA STRADINS UNIVERSITY   (Latvia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE BINDING PROTEIN; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; CARRIER PROTEIN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BACTEREMIA; CHILD; CLINICAL PRACTICE; COMMUNICABLE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; BLOOD; LATVIA; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; PROSPECTIVE STUDY;

ACUTE-PHASE PROTEINS; ADOLESCENT; BACTEREMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HMGB1 PROTEIN; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-6; LATVIA; MALE; MEMBRANE GLYCOPROTEINS; PROSPECTIVE STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 77949477128     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-28     Document Type: Article

References (37)

1. Proulx F, Fayon M, Farrell CA, Lacroix J, Gauthier M. Epidemiology of sepsis and multiple organ dysfunction syndrome in children. Chest 1996, 109:1033-1037. 10.1378/chest.109.4.1033, 8635327.
2. Watson RS, Carcillo JA. Scope and epidemiology of pediatric sepsis. Pediatric Crit Care 2005, 6(Suppl 3):3-4.
3. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus D. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003, 167:695-701. 10.1164/rccm.200207-682OC, 12433670.
4. Gardovska D, Laizâne G, Grope I. Sepsis outcomes and early diagnostic peculiarities in tertiary level Children's hospital in Latvia. Riga Stradins University Scientific Proceedings 2001, 77-83.
5. Randolph AG. The purpose of the 1st International Sepsis Forum on Sepsis in Infants and Children. Pediatr Crit Care Med 2005, 6(Suppl 3):S1-S2.
6. Brilli RJ, Goldstein B. Pediatric sepsis definitions: past, present, future. Pediatr Crit Care Med 2005, 6(Suppl 3):6-8.
7. Mishra K, Jacobs SE, Doyle LW, Garland SM. Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 2006, 91(3):F208-212. 10.1136/adc.2004.064188, 2672708, 16632649.
8. Sunden-Cullberg J, Norrby-Teglund A, Teutiger CJ. The role of high mobility group box-1 protein in severe sepsis. Curr Opin in Infec Dis 2006, 19:231-236.
9. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellio M, Che J, Frasier A, Yang H, Ivanova S, Borovikova L. HMGB-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251. 10.1126/science.285.5425.248, 10398600.
10. Gaini S, Pedersen SS, Koldkjar OG, Pedersen C, Moller HJ. High mobility group box-1 protein in patients with suspected community - acquired infections and sepsis: a prospective study. Crit Care 2007, 11:R32. 10.1186/cc5715, 2206448, 17346334.
11. Hatada T, Wada H, Nobori T, Okabayashi K, Maruyama K, Abe Y, Uemoto S, Yamada S, Maruyama I. Plasma concentrations and importance of High Mobility Group Box1 protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Tromb Haemost 2005, 94:975-979.
12. Gaini S, Koldkjar OG, Moller HJ, Pedersen C, Pedersen SS. A comparision of high- mobility group box-1 protein, lipopolysaccharide - binding protein and procalcitonin in severe community - acquired infections and bacteraemia: a prospective study. Crit Care 2007, 11:R76. 10.1186/cc5967, 2206511, 17625012.
13. Meisner M. Biomarkers of sepsis: clinical useful?. Curr Opin Crit Care 2005, 11:473-480. 10.1097/01.ccx.0000176694.92883.ce, 16175035.
14. Berner R, Furll B, Stelter F, Drose J, Muller HP, Schutt C. Elevated levels of lipopolysaccharide-binding protein and soluble CD14 in plasma in neonatal early-onset sepsis. Clin Diagn Lab Immunol 2002, 9:440-445. 119928, 11874891.
15. Ubenauf KM, Krueger M, Henneke P, Berner R. Lipopolysaccharide binding protein is a potential marker for invasive bacterial infections in children. The Ped Infec Dis J 2007, 26:159-162.
16. Pavcnik-Arnol M, Hojker S, Derganc M. Lipopolysaccharide - binding protein in critically ill neonates and children with suspected infection: Comparision with procalcitonin, interleukin-6, and C - reactive protein. Intensive Care Med 2004, 30:1454-1460. 10.1007/s00134-004-2307-4, 15127192.
17. Ng PC, Li K, Wong RP. Proinflammatory and anti - inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003, 88:F209-213. 10.1136/fn.88.3.F209, 1721542, 12719394.
18. Carcillo JA, Planquois JS, Goldstein B. Early markers of infection and sepsis in newborns and children. Advances in Sepsis 2006, 4:118-125.
19. Dahmet MK, Randolph A, Viatli S, Quasney MQ. Genetic polymorphisms in sepsis. Pediatric Crit Care Med 2005, 6(Suppl 3):61-73.
20. Ng PC, Lam HS. Diagnostic markers for neonatal sepsis. Curr Opin Pediatr 2006, 18:125-131. 10.1097/01.mop.0000193293.87022.4c, 16601490.
21. Goldstein B, Giroir B, Randolph A, . the members of the International Consensus Conference on Pediatric Sepsis International Pediatric Sepsis Consensus Conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005, 6(Suppl 3):2-8. 10.1097/01.PCC.0000149131.72248.E6, 15636651, the members of the International Consensus Conference on Pediatric Sepsis.
22. See LL. Bloodstream infection in children. Pediatr Crit Care Med 2005, 6(3 Suppl):S42-4. 10.1097/01.PCC.0000161945.98871.52, 15857557.
23. Yang H, Ochani M, Li J, Tanovic M, Harris HE, Susarla S, Ulloa L, Wang H, DiRaimo R, Czura CJ, Wang H, Roth J, Warren HS, Fink MP, Fenton MJ, Andersson U, Tracey KJ. Reversing established sepsis with antagonists of endogenous HMGB1. Proc Natl Acad Sci USA 2004, 101:296-301. 10.1073/pnas.2434651100, 314179, 14695889.
24. Wang H, Vishnubhakat JM, Bloom O, Zhang M, Ombrellino M, Sama A, Tracey KJ. Proinflammatory cytokines (tumor necrosis factor and interleukin1) stimulates release of high mobility group protein 1 by pituicytes. Surgery 1999, 126:389-392.
25. Sunden-Cullberg J, Norrby-Teglund A, Rouhianen A, Rauvala H, Herman G, Tracey KJ, Lee ML, Andersson J, Tokics L, Treutiger CJ. Persistent elevation of high mobility group box -1 protein (HMGB1) in patients with severe sepsis and septic sock. Crit Care Med 2005, 33:564-573. 10.1097/01.CCM.0000155991.88802.4D, 15753748.
26. Angus DC, Yang L, Kong L, Kellum JA, Delude RL, Tracey KJ, Weissfeld L, . GenIMS Investigators Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis. Crit Care Med 2007, 35:1061-1067. 10.1097/01.CCM.0000259534.68873.2A, 17334246, GenIMS Investigators.
27. Fink MP. Bench- to-bedside review: High - mobility box 1 and critical illness. Critical Care 2007, 11:229. 10.1186/cc6088, 2556731, 17903310.
28. Yasuda T, Ueda T, Takeyama Y, Shinzeki M, Sawa H, Nakajima T, Ajiki T, Fujino Y, Suzuki Y, Kuroda Y. Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas 2006, 33:359-363. 10.1097/01.mpa.0000236741.15477.8b, 17079940.
29. Blairon L, Wittebole X, Laterre PF. Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections. J Infect Dis 2003, 187:287-291. 10.1086/346046, 12552453.
30. Froon AH, Bemelmans MH, Greve JW, Linden CJ, Buurman WA. Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: Correlation with plasma creatinine values. Crit Care Med 1994, 22:803-809. 10.1097/00003246-199405000-00015, 8181289.
31. Gaini S, Koldkjar, Pedersen C, Pedersen SS. Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care 2006, 10:R53. 10.1186/cc4866, 1550885, 16569262.
32. Pavcnik-Arnol M, Hojker S, Derganc M. Lipopolysaccharide-binding protein, lipopolysaccharide, and soluable CD14 in sepsis of critical ill neonates and children. Inten Care Med 2007, 33:1025-1032.
33. Kocabas E, Sarikcioglu A, Aksaray N, Seydaoglu G, Seyhun Y, Yaman A. Interleukin-6 and lipopolysaccharide-binding protein in acute appendicitis in children. Scand J Clin Lab Invest 2007, 67:197-206. 10.1080/00365510601010397, 17365999.
34. Mokart D, Merlin M, Sannini A. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. BJA 2005, 94:767-773. 10.1093/bja/aei143, 15849208.
35. Miyaoka K, Iwase M, Suzuki R, Kondo G, Watanabe H, Ito D, Nagumo M. Clinical evaluation of circulating interleukin-6 and interleukin-10 levels after surgery induced inflammation. J Surg Res 2005, 125:144-150. 10.1016/j.jss.2004.12.001, 15854666.
36. Silveira RC, Procionoy RS. Evaluation of interleukin-6, tumor necrosis factor-alpha and interleukin- 1 beta for early diagnosis of neonatal sepsis. Acta Paediatr 1999, 88:647-650. 10.1080/08035259950169314, 10419250.
37. Kocabas E, Sarikcioglu A, Aksaray N, Seydaaaaoglu. Role of procalcitonin, C reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor alfa in the diagnosis of neonatal sepsis. The Turkish Journal of Pediatrics 2007, 49:7-20.